U.S. Healthcare Services Stock News

In May 2026, Starbucks announced and priced cash tender offers for several series of its outstanding senior notes, accepting early tenders up to an increased Aggregate Cap of US$1.30 billion and cancelling the purchased debt as part of its balance sheet management. The tender offers drew very strong bondholder participation, with valid tenders totaling about US$2.60 billion and triggering proration and early settlement mechanics that highlight investor interest in reshaping Starbucks’ debt...

Abbott Laboratories (NYSE:ABT) secured US and European clearance for its Ultreon 3.0 AI-powered coronary imaging platform, aimed at improving decision support during stent placement. The company received CE Mark in Europe for Libre Duo, a dual continuous glucose-ketone sensor designed for more comprehensive diabetes management. Abbott plans to present new evidence on its cancer diagnostics portfolio at the ASCO Annual Meeting, focusing on early detection and treatment guidance. Updated...

Why DraftKings' latest regulatory headwinds matter for investors DraftKings (DKNG) has come under pressure after proposed tax hikes in key sports betting states and tighter federal scrutiny of prediction markets, along with plans to close its Wrigley Field retail sportsbook by May 31, 2026. See our latest analysis for DraftKings. Despite the recent share price pressure around tax and regulatory news, DraftKings has seen a 6.7% 90 day share price return. However, the year to date share price...

Coursera (COUR) has been drawing investor attention after recent trading, with the stock at US$5.32 and returns down over the past month and past 3 months. This has prompted closer scrutiny of its online education business. See our latest analysis for Coursera. Looking beyond the recent pullback, the stock’s 1-day and 7-day share price gains contrast with its weaker 30-day and year to date share price returns. At the same time, the 1-year and multi year total shareholder returns show a much...

Kingsoft Cloud Holdings (NasdaqGS:KC) opened Q1 2026 with revenue of C¥2.7b and a basic EPS loss of C¥1.13. Trailing twelve month figures show revenue of C¥10.3b and a cumulative EPS loss of C¥3.36. Over recent quarters the company has reported revenue of C¥2.2b in Q4 2024, C¥2.0b in Q1 2025 and C¥2.7b in Q1 2026. Quarterly EPS losses ranged from C¥0.80 in Q4 2024 to C¥1.71 in Q2 2025 and C¥1.13 in the latest quarter, highlighting how efficiently revenue may eventually translate into...

Capri Holdings (CPRI) just wrapped FY 2026 with Q4 revenue of US$796 million and a small loss, with basic EPS coming in at US$0.01, while on a trailing twelve month basis EPS was US$0.66 on revenue of US$3.5 billion. Over the past few quarters, revenue has moved between US$797 million and US$1.0 billion, with quarterly EPS ranging from a loss of US$0.28 to a profit of US$0.48, giving investors a mixed but improving read on profitability. Overall, the latest print points to tight margins and...

Many investors are considering whether Albemarle's current share price fairly reflects its potential, or if the stock might be mispriced. The stock recently closed at US$177.47, with a 4.3% gain over the past 7 days, a decline of 11.1% over the past 30 days, and returns of 23.3% year to date and 211.1% over the last year. Recent headlines around Albemarle have kept attention on the stock, and investors are closely watching how broader sentiment toward materials and battery related companies...

Lam Research (NasdaqGS:LRCX) is in focus as AI driven demand for advanced chips supports multiyear capacity expansion plans at major memory producers. Micron has outlined a multiyear, multibillion dollar investment program, signaling sustained equipment needs that could directly involve suppliers like Lam Research. This reflects a broader industry shift toward higher AI related chip output, which is expected to influence Lam Research's order pipeline over several years. Lam Research enters...

Meta Platforms is reported to have pulled back from bidding on key non-IDFA iOS mobile ad inventory. This change directly affects a core segment of AppLovin's AXON AI ad platform business. The shift gives AppLovin (NasdaqGS:APP) more room to compete for this traffic without head-to-head bidding from Meta. AppLovin runs a large mobile advertising and app monetization platform, with AXON AI focused on matching ads to users across iOS and other ecosystems. With a major competitor stepping back...

Recently, analyst outlet StockStory flagged Crown Holdings as a stock to avoid, citing limited growth potential, slower earnings progress than peers, and pressure on gross margins from elevated input costs. The critique also argues that Crown’s large scale could actually constrain its flexibility, potentially giving smaller packaging rivals a competitive edge in capturing growth. We’ll now examine how concerns about high input costs and margin pressure may alter Crown Holdings’ existing...

Earlier this week, IREN announced a roughly US$1.60 billion deal to buy Nvidia Blackwell systems from Dell Technologies to equip its Childress, Texas data centers and fulfill a previously disclosed five-year, US$3.40 billion AI cloud services agreement. This large-scale GPU purchase underscores IREN’s accelerated move away from Bitcoin mining toward operating as an AI infrastructure provider with contracted cloud revenue. We’ll now examine how this US$1.60 billion Blackwell investment...

Virtuix secured funding from the United States Air Force to advance its AI-powered VR battlefield rehearsal platform.

Royalty Pharma recently reported strong first-quarter 2026 results, highlighting double-digit growth in portfolio and royalty receipts and continued expansion of its more than 35 marketed therapies and 20 development-stage assets. At the same time, the company has been drawing increased investor interest as a major buyer of biopharmaceutical royalties, using collaborations in areas such as oncology, rare disease and neuroscience to reinforce confidence in its long-term cash flow...

Fastenal (FAST) just reported quarterly revenue in line with expectations, but a miss on EBITDA estimates prompted a 10.8% share price drop. This has put the focus squarely on how the company is balancing growth and profitability. See our latest analysis for Fastenal. That EBITDA miss came after a strong run, with the share price still up 10.83% year to date and a 5 year total shareholder return of 92.79%. However, recent 3 month momentum has faded slightly. If this earnings move has you...

Earlier this month, Kraft Heinz’s JELL-O brand launched JELL-O Simply, a permanent line of gelatin and pudding desserts made with real fruit juice, no FD&C colors or artificial sweeteners, and less sugar in ready-to-eat products, alongside a limited-time KD Mac & Cheesecake dessert in Canada and upcoming investor participation at Deutsche Bank’s Global Consumer Conference. These moves highlight Kraft Heinz’s push to refresh iconic brands with simpler ingredient profiles and playful line...

Modine Manufacturing (MOD) just closed out FY 2026 with Q4 revenue of US$954.4 million and basic EPS of US$1.36, alongside trailing 12 month revenue of US$3.2 billion and EPS of US$2.26. These results reflect a year shaped by both solid quarterly profits and a large one off loss. Over recent periods, the company has seen quarterly revenue move from US$647.2 million with EPS of US$0.92 in FY 2025 Q4 to FY 2026 quarterly figures ranging between US$682.8 million and US$954.4 million. Over the...

Veradigm (MDRX) has just put fresh numbers on the table for FY 2024, with trailing 12 month revenue of US$594.4 million and a reported loss of US$291.5 million, alongside basic EPS of US$2.7 in the red. This sets a clear backdrop of revenue scale paired with negative earnings. The company has seen trailing revenue hold in a tight band between US$588.0 million and US$625.9 million over recent periods, while net income swung from a profit of US$49.2 million to a loss of US$291.5 million. This...

For investors assessing whether Motorola Solutions at US$408.71 represents a solid opportunity or is already pricing in a lot of optimism, this article walks through what the numbers indicate about value. The stock is up 3.2% over the past week, down 5.3% over the past month, up 7.3% year to date, and its return over the past year declined 1.8%, while the 3 year and 5 year returns sit at 49.8% and 108.9% respectively. Recent attention on Motorola Solutions has focused on its role in mission...

Hippocratic AI has reached 10 million patient calls on DigitalOcean’s AI-Native Cloud, in collaboration with NVIDIA. The milestone comes from production use in healthcare, a sector that relies on high reliability and safety. The partnership gives DigitalOcean Holdings (NYSE:DOCN) direct exposure to real world AI workloads beyond test or pilot projects. For investors tracking NYSE:DOCN, this healthcare milestone sits at the intersection of cloud infrastructure and applied AI. DigitalOcean is...

Lockheed Martin (LMT) has just broken ground on a new 87,000 square foot Munitions Production Center in Troy, Alabama, as part of a multi year investment of more than US$9 billion to expand missile defense output. See our latest analysis for Lockheed Martin. Recent contract wins in Canada and with the U.S. Navy, alongside the Alabama munitions expansion and upcoming Bernstein conference appearance, sit against a share price of US$531.14. Short term returns have been softer after a 90 day...

Veracyte recently highlighted phase III clinical data for its Prosigna Breast and Decipher Prostate tests at the 2026 ASCO Annual Meeting, underscoring their use in guiding chemotherapy decisions. This latest clinical evidence, alongside expectations for multiple new product launches within 18 months, reinforces Veracyte’s effort to broaden its diagnostics portfolio and address new oncology markets. Next, we’ll examine how the phase III ASCO data for Prosigna and Decipher might reshape...

Amdocs (DOX) Q2 2026 earnings: steady top line, softer EPS, and a margins story investors will focus on Amdocs (DOX) has reported Q2 2026 revenue of US$1,172 million and basic EPS of US$1.29, with the stock trading around US$61.29 as investors weigh the latest set of numbers. The company has seen quarterly revenue move from US$1,110 million in Q1 2025 to US$1,172 million in Q2 2026, while basic EPS has ranged from US$1.34 to US$1.46 in early 2025 to US$1.29 this quarter, setting a clear track...

Recently, agilon health was reported to be facing underwhelming customer growth, ongoing cash burn and a projected flat sales outlook for the next 12 months, intensifying scrutiny of its value-based care platform for seniors. An important implication is that doubts about the long-term viability of agilon health's business model are growing just as it aims to transform Medicare-focused primary care. We’ll now explore how concerns about flat near-term sales could influence agilon health’s...

Amentum Holdings (AMTM) is back on investors’ radar after its recent Q1 earnings, where revenue aligned with expectations but EPS fell short, and the stock has declined since that update. At the same time, the company has created a new Chief AI Architect role, appointing Dr. Sam Nazari to lead Amentum-wide AI integration across defense, intelligence, energy, space, and commercial clients. See our latest analysis for Amentum Holdings. The Q1 EPS miss appears to have reset expectations. The...